Target intelligence / Profile preview

RABGAP1L divergent transcript (RABGAP1L-DT)

Target: RABGAP1L-DT
Molecular classification: Other, long non-coding RNA, lncRNA

Overview

RABGAP1L divergent transcript (RABGAP1L-DT) is a human long non-coding RNA (lncRNA) located at chromosome 1q25.1, transcribed from the region adjacent and divergent to the protein-coding RABGAP1L gene[5][8][9]. It is not known to encode a protein, and there is currently no evidence supporting its role as a receptor, enzyme, transporter, or other classical therapeutic target. Its function, disease relevance, or involvement in cellular processes has not yet been established or reported in the literature or public databases. Thus, RABGAP1L-DT should not be confused with the protein-coding RABGAP1L gene or its protein product.

Other names: RABGAP1L divergent transcriptRABGAP1L-DT

Beyond the preview

Go deeper on RABGAP1L divergent transcript (RABGAP1L-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RABGAP1L divergent transcript (RABGAP1L-DT).

Explore the full profile